Active	Status	Sponsor type	Region	Phase	Filter
11 Active 5 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Qu, Yan
NCT05892653: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors	Terminated	1	15	RoW	ABM-1310	ABM Therapeutics Shanghai Company Limited	Primary Malignant Brain Tumor	08/24	08/24
Yan, Qu
NCT05892653: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors	Terminated	1	15	RoW	ABM-1310	ABM Therapeutics Shanghai Company Limited	Primary Malignant Brain Tumor	08/24	08/24